April 15, 2026
Verismo Therapeutics
Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.
- Round
- —
- Amount raised
- $28M
- Lead investor
- BRV Capital Management
- Industry
- Biotechnology
- Headquarters
- Philadelphia, United States
- Employees
- 11-50
- Website
- verismotherapeutics.com
- View profile →
Other investors
- DongKoo Bio&Pharma
- HLB innovation
- Hong Leong Bank
- Institute for Follicular Lymphoma Innovation
- ScaleReady
Source: Crunchbase snapshot 2026-05-15